BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 22305422)

  • 1. Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses.
    Baudo A; Incesu RB; Morra S; Scheipner L; Jannello LMI; de Angelis M; Siech C; Tian Z; Acquati P; Tilki D; Longo N; Ahyai S; de Cobelli O; Briganti A; Chun FKH; Saad F; Shariat SF; Carmignani L; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Apr; 22(2):181-188. PubMed ID: 38042729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma.
    Schep DG; Vansantvoort J; Dayes I; Lukka H; Quan K; Kapoor A; Chow T; Chu W; Swaminath A
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):832-837. PubMed ID: 38092258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on renal cancer care.
    Yildirim H; Bins AD; van den Hurk C; van Moorselaar RJA; van Oijen MGH; Bex A; Zondervan PJ; Aben KKH
    World J Urol; 2024 Apr; 42(1):231. PubMed ID: 38613582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview.
    Knight A; Gunn AJ
    Curr Oncol Rep; 2024 May; ():. PubMed ID: 38767829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of pre-operative imaging findings in presumed clinical T1a renal cell carcinomas.
    Nakashima K; Kitagawa Y; Izumi K; Mizokami A; Gabata T; Namiki M
    Oncol Lett; 2016 May; 11(5):3189-3193. PubMed ID: 27123087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convolutional neural networks for the differentiation between benign and malignant renal tumors with a multicenter international computed tomography dataset.
    Klontzas ME; Kalarakis G; Koltsakis E; Papathomas T; Karantanas AH; Tzortzakakis A
    Insights Imaging; 2024 Jan; 15(1):26. PubMed ID: 38270726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma.
    Lee J; Kim J; Kim JC; Ham WS; Han WK; Rha KH; Choi YD; Jang WS
    Yonsei Med J; 2022 Feb; 63(2):173-178. PubMed ID: 35083903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic analysis of stage pT1b kidney neoplasms for optimal surgical margins of nephron-sparing surgery.
    Li G; Luo Q; Lang Z; Li Y; Wang A; Wang K; Niu Y
    Clin Transl Oncol; 2018 Sep; 20(9):1196-1201. PubMed ID: 29564715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Enucleation for Renal Cell Carcinoma.
    Smith ZL; Malkowicz SB
    J Kidney Cancer VHL; 2015; 2(2):64-69. PubMed ID: 28326260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.
    Laganosky DD; Filson CP; Master VA
    Curr Urol Rep; 2017 Jan; 18(1):8. PubMed ID: 28211006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor enucleation specimens of small renal tumors more frequently have a positive surgical margin than partial nephrectomy specimens, but this is not associated with local tumor recurrence.
    Wang L; Hughes I; Snarskis C; Alvarez H; Feng J; Gupta GN; Picken MM
    Virchows Arch; 2017 Jan; 470(1):55-61. PubMed ID: 27778094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Width of Peritumoral Surgical Margin in Open and Robotic Partial Nephrectomy: A Propensity Score Matched Analysis.
    Oh JJ; Lee JK; Kim K; Byun SS; Lee SE; Hong SK
    PLoS One; 2016; 11(6):e0158027. PubMed ID: 27336438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical histologic appraisal of the pseudocapsule of small renal tumors.
    Wang L; Feng J; Alvarez H; Snarskis C; Gupta G; Picken MM
    Virchows Arch; 2015 Sep; 467(3):311-7. PubMed ID: 26089143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of postoperative renal functional damage after nephron-sparing surgery.
    Qi J; Yu Y; Huang T; Bai Q; Kang J; Liang J; Wu Y
    World J Surg Oncol; 2013 Aug; 11():216. PubMed ID: 23987305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma.
    Chen XS; Zhang ZT; Du J; Bi XC; Sun G; Yao X
    Urology; 2012 Apr; 79(4):836-9. PubMed ID: 22305422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less in diameter].
    Li QL; Guan HW; Zhang LZ; Zhang QP; Wang FP; Liu YJ
    Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):81-3. PubMed ID: 12783662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less.
    Li QL; Guan HW; Zhang QP; Zhang LZ; Wang FP; Liu YJ
    Eur Urol; 2003 Oct; 44(4):448-51. PubMed ID: 14499679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.